Alternate Health Corp · OTC:AHGIF
Alternate Health — Investor Presentation (October 2017)
30 slides from Alternate Health's investor presentation, Oct 12, 2017
Slide 1: Alternate Health Corp. October 2017
ALTERNATE HEALTH CORP. CSE:AHG | OTC:AHGIF | www.alternatehealth.ca October 2017 1
Slide 2: Disclaimers
DISCLAIMERS FORWARD LOOKING STATEMENTS This presentation contains information about the company’s future plans and financial projections that have been prepared on the basis of assumptions as to future events which management expects to take place and the actions management expects to take as of the
Slide 3: Corporate Summary
CORPORATE SUMMARY Company Background Alternate Health is an international medical cannabis company that uses technology, research, and clinical services to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices. Alternate Health has establish
Slide 4: Market Capitalization
ALTERNATE HEALTH CORP Market Capitalization Canadian Securities Exchange | AHG LABORATORY TESTING OTCQB | AHGIF Market Cap (Sept 27th, 2017) $156.0M Share Price (Sept 27th, 2017) $3.00 LIFE SCIENCES Listing Share Price (Jan 24, 2017) $3.28 52 week trading range $8.90 - $1.80 Outstanding Warrants 1,3
Slide 5: Company History
COMPANY HISTORY Corporate Structure and Summary Alternate Health Corp is a Canadian corporation listed in Jan 2017 in a reverse takeover by privately held Alternate Health Inc. Corporate offices: Toronto, Canada and San Antonio, TX Alternate Health office Toronto Trading on CSE: AHG and OTCQB: AHGIF
Slide 6: Company Cannabis Policy
COMPANY CANNABIS POLICY Alternate Health is fully cognizant of the current federal status of the cannabis plant Alternate Health does not cultivate, manufacture, recommend or dispense marijuana in any form or fashion and business activities are limited to arms-length solutions and operations for the
Slide 7: Company Organization
COMPANY ORGANIZATION Alternate Health Corp. Publicly Traded CSE and OTC Alternate Health Inc. Alternate Health USA Inc. CanaPass & VIP Patient Subsidiary of AH specifically for U.S. operations Office: Toronto, ON Office: San Antonio, TX Alternate Health Labs Inc. Alternate Health Life Sciences, LLC.
Slide 8: Business Operations
ALTERNATE HEALTH Business Operations Proprietary software system for the Clinical laboratory that processes Media company that aggregates Product development company management of medical cannabis lab tests to aid physicians in the Alternate Health’s medical research that analyzes data and research
Slide 9: CanaPass Software System
CANAPASS SOFTWARE SYSTEM CanaPass Platform (formerly CanaCard) CanaPass manages the end-to-end transactions for safe access to medical cannabis in the Canadian market Seamlessly connects the physician, patient and dispensing organization across a closed-loop, PIPEDA-compliant platform For physicians
Slide 10: CanaPass Software System: Marketing and Distribution
CANAPASS SOFTWARE SYSTEM Marketing and Distribution CanaPass is a market mover, as there is no other system available that connects the physician, patient and dispensing organization across a transaction-based EMR system Due to the positive reception in the Canadian market and the lack of actual com
Slide 11: CanaPass Deployment through National Access Cannabis
CANAPASS SOFTWARE SYSTEM Deployment in Canada through National Access Cannabis Currently implementing CanaPass into all National Access Cannabis clinics across the country, which serve over 10,000 patients total Alternate Health’s strategic partnership with NAC also included a $1.6M investment into
Slide 12: Alternate Health Labs Inc.
ALTERNATE HEALTH LABS INC. Alternate Health Clinical Laboratory AHL is a subsidiary of Alternate Health that operates as an independent clinical laboratory located in San Antonio, Texas; AHL specializes in providing diagnostic and toxicology testing By operating state-of-the-art instrumentation in s
Slide 13: Alternate Health Labs: Developments, Sales and Future Plans
ALTERNATE HEALTH LABS INC. RECENT DEVELOPMENTS SALES AND DISTRIBUTION FUTURE PLANS AHL is transitioning to an in-network lab that will AHL will engage in-house and contracted sales Alternate Health Labs is currently evaluating bill insurance directly for toxicology, blood and forces for maximum mark
Slide 14: Alternate Medical Media
ALTERNATE MEDICAL MEDIA Company Background Alternate Medical Media has extensively contributed content to a series of Continuing Medical Education (CME) programs for physicians and registered nurses wishing to expand their knowledge on the Endocannabinoid System Alternate Medical Media uses its expe
Slide 15: Alternate Rx
ALTERNATE RX Medical-Grade Product Development for the Cannabis Sector Alternate Rx is a product development company that creates medical-grade, proprietary delivery technologies to increase the efficacy and safety of medical cannabis treatments. Alternate Rx was created to address the need for more
Slide 16: VIP Patient
VIP PATIENT VIP-Patient is a proprietary EMR & practice management platform that delivers a private and secure system for HIPAA and PIPEDA compliant interactions and monitoring between the physician, the patient and ultimately the pharmacy or a third party medical services provider VIP-Patient maint
Slide 17: Neubauer Hyperbaric Neurologic Center
NEUBAUER HYPERBARIC NEUROLOGIC CENTER Alternate Health has entered a non binding agreement to acquire the Neubauer Hyperbaric Neurologic Center in Lauderdale by the Sea, Florida which is expected to be finalized and closed in Q4 2017. Having treated patients since 1972, Neubauer Hyperbaric Neurologi
Slide 18: Research and Studies at the Neubauer Center
NEUBAUER HYPERBARIC NEUROLOGIC CENTER Research and Studies at the Neubauer Center ZIKA VIRUS PTSD Alternate Health completed an initial study to treat General Wesley Clark, a retired Army General and post-Zika virus symptoms using hemp-derived former NATO Supreme Commander, who regularly cannabinoid
Slide 19: IP Portfolio
IP PORTFOLIO Exclusivity in an Emerging Market Alternate Health places priority on developing and patenting proprietary technologies, processes and trade secrets in order to ensure exclusive rights to specific products and procedures. These intellectual properties strengthen Alternate Health’s prese
Slide 20: IP Portfolio: Intellectual Property
IP PORTFOLIO Intellectual Property ICD-10 PATENT CANAPASS & VIP PATIENT One of Alternate Health’s most exciting All code for software systems that have patent applications is for the process of been written by Alternate Health using predictive analytics within an developers is the exclusive intellec
Slide 21: Q1 2017 Results
Revenue of $3.9 million compared to Nil in Q1 of last year Adjusted EBITDA of $1.4 million compared to Nil in Q1 2016 Revenue for the quarter was driven by strong performance from Alternate Health Labs, a clinical laboratory acquired Net loss of $0.6 million, up from a loss of $0.1 million in Q1 of
Slide 22: Q2 2017 Results
CASH USED FOR SIGNIFICANT STRATEGIC CAPITAL Q2 Revenue of $7.2 million increased 87% compared to $3.9 INVESTMENTS IN THE QUARTER INCLUDED: million in Q1 of 2017. Revenue was Nil in Q2 of last year. $1.6 million in securities of National Access Cannabis Adjusted EBITDA of $25k compared to $1.4 millio
Slide 23: 12 Month Projections
12 MONTH PROJECTIONS Oct 1, 2017 to Sept 30, 2018 Net revenue: $75,083,000 EBITDA: $33,410,000 $29,207,000 $25,528,000 $14,491,000 $15,201,000 $11,026,000 $5,857,000 $5,512,000 $1,671,000 Net Revenue EBITDA Net Revenue EBITDA Net Revenue EBITDA Net Revenue EBITDA 4th QTR 2017 1st QTR 2018 2nd QTR 20
Slide 24: Differentiators and Market Position
The only PIPEDA-compliant, cannabis-specific 70% of clinical medicine decision making is There are dozens of companies that specialize EMR system functioning as both an online predicated upon or confirmed by medical in developing products for the medical marketplace and transaction-based system, lab
Slide 25: AHC Corporate Officers & Directors
AHC CORPORATE OFFICERS & DIRECTORS Dr. Michael Murphy, M.D Howard Mann CEO & Chairman of the Board, Executive Committee Chair Founder, Special Advisor to the Board and President of Alternate Health Inc Experience Experience Attended the University of Texas College of Pharmacy and the Founder of Alte
Slide 26: AHC Corporate Officers & Directors
AHC CORPORATE OFFICERS & DIRECTORS James Griffiths J. Bernard Rice Board Member, Executive Committee Member, Board Member, Audit Committee Chair, Compensation Committee Member, Chief Financial Officer Executive Committee Member Experience Experience Received his Master of Business Administration, is
Slide 27: AHC Corporate Officers & Directors
AHC CORPORATE OFFICERS & DIRECTORS Michael Klipper Jim Tykoliz Board Member, Compensation Committee Chair, Board Member, Compensation Committee Member, VP Research and Product Development Audit Committee Member Experience Experience A formulary chemist, entrepreneur, author, fundraiser and Co- Degre
Slide 28: AHC Corporate Officers & Directors
AHC CORPORATE OFFICERS & DIRECTORS Kristin Taylor Marcelin O’Neill Board Member, Audit Committee Member Chief Compliance Officer Experience Experience A technology industry thought leader and marketing strategist Director and CEO of Cervantes Capital Corp. that has spent over 20 years developing tru
Slide 29: AHC Corporate Officers & Directors
AHC CORPORATE OFFICERS & DIRECTORS Jade Green Jay Briggs VP Sales and Marketing VP of Operations Experience Experience Graduated Cum Laude B. Sc. from the University of Florida in Received his Master of Business Administration from the Biochemistry. University of Texas at San Antonio. Founded her ow
Slide 30: Contact Information
CONTACT INFORMATION INVESTOR RELATIONS Nancy Goertzen, CPIR 604.512.7122 n.goertzen@alternatehealth.ca ALTERNATE HEALTH CORP. CSE:AHG | OTC:AHGIF | www.alternatehealth.ca October 2017
Alternate Health — Investor Presentation (October 2017) on 6ix